Gene-Editing Shows Promise in Mouse Models of Lou Gehrig's Disease (2 of 2) (IMAGE)

American Association for the Advancement of Science (AAAS)

Gene-Editing Shows Promise in Mouse Models of Lou Gehrig's Disease (2 of 2)

Caption

CRISPR-Cas9 gene editing in motor neurons helped alleviate symptoms and increase overall survival of mouse models of amyotrophic lateral sclerosis, otherwise known as Lou Gehrig's disease. This material relates to a paper that appeared in the 20 Dec/ 2017, issue of Science Advances, published by AAAS. The paper, by T. Gaj at University of California, Berkeley in Berkeley, Calif., and colleagues was titled, "In vivo genome editing improves motor function and extends survival in a mouse model of ALS."

Credit

[Credit: Chris Bickel/ AAAS]

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.